PEOPLE - - Xenomics makes appointment:
This article was originally published in Clinica
Xenomics, an applied genomics firm, has appointed Randy White as CEO. Prior to joining the New York-based developer of noninvasive technology using urine samples rather than blood samples to evaluate genetic markers of disease, such as renal - Dr White served as CEO of Nanogen, and also served at American Medical Diagnostics, which was sold to Quest Diagnostics in 2002.
You may also be interested in...
As distribution of Regeneron’s monoclonal antibody treatment for coronavirus begins, OWS officials worry about provider confusion with Lilly’s product due to differences in preparation and administration.
The maker of prestige-inspired cosmetics at value prices follows its TikTok viral success by teaming with Kathleen Belsten, aka Loserfruit, the second most-followed female gamer on the Amazon-owned livestreaming platform Twitch.
Join us for a brief audio tour around the past week's key developments in the global biopharma industry, in this podcast version of Scrip's Five Must-Know Things.